Familial primary pulmonary hypertension (FPPH) is a well described clinical
entity in which the disease occurs in at least two first degree relatives.
It is clinically and pathologically indistinguishable from sporadic PPH. M
utations in the gene which encodes bone morphogenetic receptor 2 have recen
tly been discovered in familial and sporadic PPH. This review discusses the
basic clinical and genetic features of FPPH, and describes the research th
at led to the discovery of the disease-causing gene. Potential mechanisms o
f disease are also discussed, as well as implications for future investigat
ions.